Custom Tirzepatide Supplier - GLP-1/GIP Receptor Agonist 5mg-50mg Vials

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This synthetic peptide demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

Our pharmaceutical grade Tirzepatide (LY3298176) exhibits greater affinity for GIP receptors while maintaining significant GLP-1 receptor activity. This unique dual mechanism has shown promising results in reducing hyperglycemia in research settings. The compound mimics natural GIP action at GIP receptors while providing enhanced GLP-1 receptor activation.

Available in multiple concentrations from 5mg to 50mg per vial, our Tirzepatide meets strict quality standards with purity exceeding 99.5%. The white powder form ensures easy handling and preparation for research applications. Proper storage in cool, dry conditions maintains product stability.

For research institutions requiring specific formulations, we offer custom synthesis services with flexible packaging options. Our production facility can accommodate specialized requests including custom vial sizes, labeling, and purity specifications to meet unique research requirements.

Note: This product is intended for research purposes only and not for human consumption. All orders must be placed by qualified research institutions or licensed professionals.